|
Feb 20
|
Novavax (NVAX) Declines More Than Market: Some Information for Investors
|
|
Feb 20
|
Is Trending Stock Novavax, Inc. (NVAX) a Buy Now?
|
|
Feb 20
|
Novavax to Host Conference Call to Discuss Fourth Quarter and Full Year 2024 Financial Results and Operational Highlights on February 27, 2025
|
|
Feb 19
|
Novavax to Report Q4 Earnings: Here's What You Can Expect
|
|
Feb 10
|
Novavax (NVAX) Outperforms Broader Market: What You Need to Know
|
|
Jan 24
|
Moderna Yo-Yos After European Officials Ink Supply Deal For Covid Shots
|
|
Jan 22
|
Wall Street Analysts Predict an 81.61% Upside in Novavax (NVAX): Here's What You Should Know
|
|
Jan 22
|
Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It
|
|
Jan 21
|
Novavax, Inc. (NVAX) Stock: The Under-the-Radar Stock Poised for Massive Upside in 2025
|
|
Oct 3
|
Novavax (NVAX) Moves 19.2% Higher: Will This Strength Last?
|
|
Sep 26
|
Time to Order Your Free At-Home Covid Tests. Here’s How.
|
|
Sep 26
|
Novavax Stock Rocketed This Year, But Challenges Persist. Is It A Buy Or A Sell?
|
|
Sep 25
|
Novavax Names Dr. Ruxandra Draghia-Akli as New Executive Vice President and Head of Research & Development
|
|
Sep 3
|
FDA Approves Novavax's Updated COVID Vaccine Targeting Currently Circulating Variants
|
|
Sep 3
|
Company News for Sep 3, 2024
|
|
Sep 2
|
Novavax Stock Up 9% on FDA Nod for Updated COVID-19 Vaccine
|
|
Sep 2
|
Novavax wins FDA emergency approval for updated Covid-19 vaccine
|
|
Aug 30
|
FDA approves Novavax's updated COVID-19 vaccine
|
|
Aug 30
|
US clears updated COVID shots from Novavax, adding a 3rd fall vaccine option
|
|
Aug 30
|
Novavax 2024-2025 Formula COVID-19 Vaccine Now Authorized and Recommended for Use in the U.S.
|